Inhibitory effect of IVIG on IL-17 production by Th17 cells is independent of anti-IL-17 antibodies in the immunoglobulin preparations (Q43707482)

26 November 2017

title

Inhibitory effect of IVIG on IL-17 production by Th17 cells is independent of anti-IL-17 antibodies in the immunoglobulin preparations (English)

1 reference

26 November 2017

1 reference

5

1 reference

26 November 2017

6

1 reference

Sébastien Lacroix-Desmazes

26 November 2017

Pushpa Hegde

3

0 references

Mohan S. Maddur

object named as

Mohan S Maddur

series ordinal

1

0 references

object named as

Sébastien Lacroix-Desmazes

series ordinal

4

0 references

author name string

Meenu Sharma

series ordinal

2

1 reference

26 November 2017

publication date

7 August 2012

1 reference

Journal of Clinical Immunology

26 November 2017

published in

1 reference

26 November 2017

volume

33 Suppl 1

1 reference

26 November 2017

page(s)

S62-6

1 reference

https://scigraph.springernature.com/pub.10.1007/s10875-012-9752-6

26 November 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

Intravenous immunoglobulin therapy in rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

Mechanisms of action of intravenous immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

Adoptive-transfer effects of intravenous immunoglobulin in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

What is the contents of the magic draft IVIg?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

Autoimmunity as a predisposition for infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

Novel cellular and molecular mechanisms of induction of immune responses by aluminum adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

Indirect inhibition of in vivo and in vitro T-cell responses by intravenous immunoglobulins due to impaired antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes"

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

Immunomodulation by intravenous immunoglobulin: role of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

Intravenous immunoglobulin expands regulatory T cells in autoimmune rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

Intravenous immunoglobulin attenuates airway inflammation through induction of forkhead box protein 3-positive regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

Comparison of different IVIg preparations on IL-17 production by human Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9752-6

10.1007/S10875-012-9752-6

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

26 November 2017

1043316463

0 references

1 reference